Indication

Hypotrichosis of eyelid lashes

Hypotrichosis of eyelid lashes describes an integumentary and ocular adnexal condition characterized by an inadequate amount, density, length, or thickness of the cilia along the eyelid margins. Read more about Hypotrichosis of eyelid lashes

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Hypotrichosis of eyelid lashes therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Hypotrichosis of eyelid lashes preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hypotrichosis of eyelid lashes.

Hypotrichosis of eyelid lashes describes an integumentary and ocular adnexal condition characterized by an inadequate amount, density, length, or thickness of the cilia along the eyelid margins.

It may present congenitally as part of genetic ectodermal syndromes or arise as an acquired state secondary to aging, localized eyelid inflammation such as blepharitis, mechanical trauma, chemotherapy, or systemic alopecia.

Pathophysiologically, the condition involves follicular dysfunction marked by shortened anagen growth phases, prolonged telogen resting intervals, or diminished follicular miniaturization.

Clinically, affected individuals exhibit sparse, fine, or absent eyelashes, which can compromise the natural ocular barrier against foreign debris and moisture while impacting facial aesthetics.

Personalize your experience

Follow Hypotrichosis of eyelid lashes and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it